AVNS Avanos Medical Inc

Price (delayed)

$14.52

Market cap

$667.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.53

Enterprise value

$730.47M

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The quick ratio has increased by 48% year-on-year and by 39% since the previous quarter
Avanos Medical's debt has decreased by 19% YoY and by 16% from the previous quarter
The company's equity fell by 33% YoY and by 33% QoQ

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
46M
Market cap
$667.97M
Enterprise value
$730.47M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.81
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
Earnings
Revenue
$687.8M
Gross profit
$381.3M
Operating income
-$400.1M
Net income
-$392.1M
EBIT
-$396.9M
EBITDA
-$351.4M
Free cash flow
$82.9M
Per share
EPS
-$8.53
EPS diluted
-$8.53
Free cash flow per share
$1.8
Book value per share
$18.03
Revenue per share
$14.97
TBVPS
$12.76
Balance sheet
Total assets
$1.15B
Total liabilities
$325.7M
Debt
$170.2M
Equity
$828.5M
Working capital
$227.5M
Liquidity
Debt to equity
0.21
Current ratio
2.37
Quick ratio
1.45
Net debt/EBITDA
-0.18
Margins
EBITDA margin
-51.1%
Gross margin
55.4%
Net margin
-57%
Operating margin
-58.2%
Efficiency
Return on assets
-25.6%
Return on equity
-34.8%
Return on invested capital
-74%
Return on capital employed
-40.2%
Return on sales
-57.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
1.18%
1 week
2.54%
1 month
-3.52%
1 year
-25.12%
YTD
-8.79%
QTD
1.33%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$687.8M
Gross profit
$381.3M
Operating income
-$400.1M
Net income
-$392.1M
Gross margin
55.4%
Net margin
-57%
The revenue is up by 2.2% year-on-year

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
N/A
P/B
0.81
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
The company's equity fell by 33% YoY and by 33% QoQ
AVNS's price to book (P/B) is 27% less than its 5-year quarterly average of 1.1
The P/S is 52% lower than the 5-year quarterly average of 2.0 and 26% lower than the last 4 quarters average of 1.3
The revenue is up by 2.2% year-on-year

Efficiency

How efficient is Avanos Medical business performance

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The quick ratio has increased by 48% year-on-year and by 39% since the previous quarter
The total assets has contracted by 32% YoY and by 30% from the previous quarter
Avanos Medical's debt is 79% less than its equity
The company's equity fell by 33% YoY and by 33% QoQ
The debt to equity has grown by 31% from the previous quarter and by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.